Highlights

02-10 DAX Struggles to Gain Traction as AI and Interest Rate Worries Weigh on Investors RE
02-09 US Drops Antitrust Investigation Against Symrise RE
02-09 Symrise says U.S. Department Of Justice drops antitrust probe RE
02-09 Symrise confirms investigations against Symrise in antitrust proceedings by U.S. Department of Justice discontinued RE
02-06 Berenberg Revises Symrise Price Target, Estimates Amid Sustained Soft End-market Projections MT
01-13 German DAX Index Subdued; Symrise Shares Shine MT
01-13 Symrise Continues Recovery Thanks to Business Sale and Share Buybacks DP
01-13 Symrise Accelerates Recovery – Terpene Sale and Share Buybacks DP
01-13 Focus on inflation and corporate earnings Zonebourse
01-13 Symrise Misses Forecast and Plans Share Buyback RE
01-12 Symrise announces buyback amid advanced talks to sell terpenes unit AN
01-12 Germany's Symrise says potential unit sale, Swedencare impairment to hurt earnings RE
01-12 Symrise AG resolves a share buy-back program in the amount of EUR 400 million RE
01-12 Germany's Symrise to sell terpenes business, take $169 million impairment charge RE
11-07 Deutsche Bank says Honduras and Suriname partner with Deutsche Bank, Bayer, Siemens and Symrise to mobilize financial support for rainforest protection RE
11-04 IFF beats quarterly results estimates on resilient demand RE
30/10/25 Berenberg Cuts Symrise EPS Estimates After Q3 Sales Miss, Guidance Downgrade MT
28/10/25 Symrise lowers FY organic growth outlook to 2.3%-3.3% from 3%-5% due to macroeconomic challenges RE
28/10/25 Symrise trims 2025 growth outlook again as demand softens RE
17/09/25 Symrise places 800 million euro bond RE
27/08/25 Fragrance maker Givaudan names new CEO, unveils 2030 growth strategy RE
14/08/25 Lanxess cuts profit guidance as tariffs weigh RE
14/08/25 Lanxess cuts profit guidance as tariffs weigh RE
30/07/25 SYMRISE AG : JP Morgan reiterates its Buy rating ZD
30/07/25 Weak Consumer Demand: Symrise Cuts Sales Outlook - Shares Under Pressure DP
No results for this search